The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health

by Robert F. Kennedy Jr.

Dr. Fishbein explained further about the Proleukin trial: “It was a serious violation of protocols and the researchers were ignoring their legal duty to report the signal. They omitted and whitewashed all these safety problems. You can’t just focus on efficacy and ignore safety.” Dr. Fishbein told AP reporter John Solomon, “The ones that were in the study, and those that wanted to get in the study, neither were being informed. NIAID feared that if they understood the risks, they would drop out.” Dr. Fishbein had entered a dangerous realm at NIAID. He was interfering with ongoing drug approvals. Tramont was angry that Dr. Fishbein was allowing concerns about patient safety to become an obstacle to the agency’s central mission of getting new drugs through the approval process with positive reviews. Tramont warned Dr. Fishbein to slow down. “You are moving too fast. You need to get to know how this place works,” Tramont told him. “We need to act more like a pharmaceutical company; we need to get patients, and get studies done.”